Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2012, Article ID 537183, 3 pages
http://dx.doi.org/10.1155/2012/537183
Case Report

A Case of Brain Metastases from Breast Cancer Treated with Whole-Brain Radiotherapy and Eribulin Mesylate

1Department of Oncology and Palliative Medicine, Nordland Hospital, P.O. Box 1480, 8092 Bodø, Norway
2Institute of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, N-9037 Tromsø, Norway

Received 4 June 2012; Accepted 26 June 2012

Academic Editors: K. Aogi and G. Di Vagno

Copyright © 2012 Carsten Nieder et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Berghoff, Z. Bago-Horvath, C. De Vries, P. Dubsky, U. Pluschnig, M. Rudas et al., “Brain metastases free survival differs between breast cancer subtypes,” British Journal of Cancer, vol. 106, pp. 440–446, 2012. View at Publisher · View at Google Scholar
  2. S. Dawood, X. Lei, J. K. Litton, T. A. Buchholz, G. N. Hortobagyi, and A. M. Gonzalez-Angulo, “Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer,” Cancer. In press. View at Publisher · View at Google Scholar
  3. S. Ohno, K. Tanaka, C. Koga et al., “Can patients with metastatic breast cancer be cured after introduction of newer and more effective agents?” Breast Cancer, vol. 19, pp. 212–217, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. H. J. Kim, S. A. Im, B. Keam, Y. J. Kim, S. W. Han, T. M. Kim et al., “Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment,” Journal of Neuro-Oncology, vol. 106, no. 2, pp. 303–313, 2012. View at Publisher · View at Google Scholar
  5. I. Karam, A. Nichol, R. Woods, and S. Tyldesley, “Population-based outcomes after whole brain radiotherapy and re-irradiation in patients with metastatic breast cancer in the trastuzumab era,” Radiation Oncology, vol. 6, p. 181, 2011. View at Publisher · View at Google Scholar
  6. K. Aogi, H. Iwata, N. Masuda, H. Mukai, M. Yoshida, Y. Rai et al., “A phase II study of eribulin in Japanese patients with heavily pretreated metastatic breast cancer,” Annals of Oncology, vol. 23, pp. 1441–1448, 2012. View at Google Scholar
  7. J. Cortes, J. O'Shaughnessy, D. Loesch et al., “Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study,” The Lancet, vol. 377, no. 9769, pp. 914–923, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Cortes, L. Vahdat, J. L. Blum et al., “Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine,” Journal of Clinical Oncology, vol. 28, no. 25, pp. 3922–3928, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. T. Vahdat, B. Pruitt, C. J. Fabian et al., “Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane,” Journal of Clinical Oncology, vol. 27, no. 18, pp. 2954–2961, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Nakajima, Y. Ishikawa, M. Furuya, T. Sano, Y. Ohno, J. Horiguchi et al., “. Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer,” Breast Cancer. In press.
  11. C. Nieder, K. Marienhagen, S. T. Astner, and M. Molls, “Prognostic scores in brain metastases from breast cancer,” BMC Cancer, vol. 9, article 105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Nieder, K. Marienhagen, R. Thamm, S. T. Astner, M. Molls, and J. Norum, “Prediction of very short survival in patients with brain metastases from breast cancer,” Clinical Oncology, vol. 20, no. 5, pp. 337–339, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Bartsch, S. Fromm, M. Rudas et al., “Intensified local treatment and systemic therapy significantly increase survival in patients with brain metastases from advanced breast cancer—a retrospective analysis,” Radiotherapy and Oncology, vol. 80, no. 3, pp. 313–317, 2006. View at Publisher · View at Google Scholar · View at Scopus